• News
  • SAN DIEGO
  • BioTech

DexCom cited as bellwether

CNBC stock commentator Jim Cramer on Friday cited San Diego’s DexCom Inc. (Nasdaq: DXCM) as a bellwether for the stock market, which should go into a turnaround on Wall Street within the next year.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Dexcom Inc.

Company Website

5555 Oberlin Drive
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
DXCM
44.82
  0.62  
+ 1.40%
519,781,000
49.83
25.49

Insider Trade Data

Date Insider Shares Type Value
08/26/2014 Moy, Jeffrey C 16,663 Exchange $140,177
08/26/2014 Pacelli, Steven Robert 30,000 Sell $1,336,861
08/26/2014 Pacelli, Steven Robert 30,000 Sell $1,336,861
08/26/2014 Pacelli, Steven Robert 30,000 Exchange $437,220
08/26/2014 Pacelli, Steven Robert 30,000 Sell $1,336,861

Dexcom Inc. Executive(s):

Terrance Gregg

  • Chief Executive Officer, Director

Kevin Sayer

  • Director, President

Patrick Murphy

  • Assist. General Counsel

Similar Companies

NAICS - -
Subscribe Today!